| # | Title | Journal | Year | Citations |
|---|
| 1 | DNA vaccine protection against SARS-CoV-2 in rhesus macaques | Science | 2020 | 978 |
| 2 | SARS-CoV-2 infection protects against rechallenge in rhesus macaques | Science | 2020 | 789 |
| 3 | Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans | Nature | 2021 | 290 |
| 4 | Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses | Npj Vaccines | 2020 | 286 |
| 5 | Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters | Nature Medicine | 2020 | 275 |
| 6 | Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19) | Lancet, The | 2018 | 269 |
| 7 | Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19 | JAMA - Journal of the American Medical Association | 2021 | 260 |
| 8 | Prospects for a safe COVID-19 vaccine | Science Translational Medicine | 2020 | 204 |
| 9 | Stabilizing the closed SARS-CoV-2 spike trimer | Nature Communications | 2021 | 139 |
| 10 | Epidemiology of Escherichia coli Bacteremia: A Systematic Literature Review | Clinical Infectious Diseases | 2021 | 116 |
| 11 | Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial | Lancet Infectious Diseases, The | 2021 | 115 |
| 12 | Mapping functional humoral correlates of protection against malaria challenge following RTS,S/AS01 vaccination | Science Translational Medicine | 2020 | 100 |
| 13 | A Universal Approach to Optimize the Folding and Stability of Prefusion-Closed HIV-1 Envelope Trimers | Cell Reports | 2018 | 93 |
| 14 | Antigen Loading of MHC Class I Molecules in the Endocytic Tract | Traffic | 2001 | 91 |
| 15 | Phase 1 Safety and Immunogenicity Study of a Respiratory Syncytial Virus Vaccine With an Adenovirus 26 Vector Encoding Prefusion F (Ad26.RSV.preF) in Adults Aged ≥60 Years | Journal of Infectious Diseases | 2020 | 78 |
| 16 | A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates | PLoS ONE | 2018 | 64 |
| 17 | Immunogenicity and Safety of an Adjuvanted Herpes Zoster Subunit Vaccine Coadministered With Seasonal Influenza Vaccine in Adults Aged 50 Years or Older | Journal of Infectious Diseases | 2017 | 63 |
| 18 | Safety and immunogenicity of two heterologous HIV vaccine regimens in healthy, HIV-uninfected adults (TRAVERSE): a randomised, parallel-group, placebo-controlled, double-blind, phase 1/2a study | Lancet HIV,the | 2020 | 58 |
| 19 | Burden of respiratory syncytial virus infection in community-dwelling older adults in Europe (RESCEU): an international prospective cohort study | European Respiratory Journal | 2021 | 55 |
| 20 | Safety and immunogenicity of a vaccine for extra-intestinal pathogenic Escherichia coli (ESTELLA): a phase 2 randomised controlled trial | Lancet Infectious Diseases, The | 2019 | 53 |
| 21 | A two-dose heterologous prime-boost vaccine regimen eliciting sustained immune responses to Ebola Zaire could support a preventive strategy for future outbreaks | Human Vaccines and Immunotherapeutics | 2017 | 51 |
| 22 | Vaccines based on replication incompetent Ad26 viral vectors: Standardized template with key considerations for a risk/benefit assessment | Vaccine | 2021 | 51 |
| 23 | Structural basis for recognition of the central conserved region of RSV G by neutralizing human antibodies | PLoS Pathogens | 2018 | 50 |
| 24 | Low-dose Ad26.COV2.S protection against SARS-CoV-2 challenge in rhesus macaques | Cell | 2021 | 49 |
| 25 | Structure-Based Design of Prefusion-Stabilized Filovirus Glycoprotein Trimers | Cell Reports | 2020 | 46 |
| 26 | Adenoviral vector type 26 encoding Zika virus (ZIKV) M-Env antigen induces humoral and cellular immune responses and protects mice and nonhuman primates against ZIKV challenge | PLoS ONE | 2018 | 45 |
| 27 | Prevention of Respiratory Syncytial Virus Infection in Healthy Adults by a Single Immunization of Ad26.RSV.preF in a Human Challenge Study | Journal of Infectious Diseases | 2022 | 45 |
| 28 | Nonhuman primate to human immunobridging to infer the protective effect of an Ebola virus vaccine candidate | Npj Vaccines | 2020 | 45 |
| 29 | Safety and immunogenicity of Ad26 and MVA vaccines in acutely treated HIV and effect on viral rebound after antiretroviral therapy interruption | Nature Medicine | 2020 | 43 |
| 30 | Safety and Immunogenicity of the Ad26.RSV.preF Investigational Vaccine Coadministered With an Influenza Vaccine in Older Adults | Journal of Infectious Diseases | 2021 | 43 |
| 31 | Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques | Nature | 2021 | 40 |
| 32 | Ad26.COV2.S protects Syrian hamsters against G614 spike variant SARS-CoV-2 and does not enhance respiratory disease | Npj Vaccines | 2021 | 38 |
| 33 | Serotonergic Approaches in Parkinson’s Disease: Translational Perspectives, an Update | ACS Chemical Neuroscience | 2017 | 37 |
| 34 | First-in-Human Randomized, Controlled Trial of Mosaic HIV-1 Immunogens Delivered via a Modified Vaccinia Ankara Vector | Journal of Infectious Diseases | 2018 | 35 |
| 35 | Adenovirus vector‐based prime‐boost vaccination via heterologous routes induces cervicovaginal CD8+ T cell responses against HPV16 oncoproteins | International Journal of Cancer | 2018 | 35 |
| 36 | One single, fast and robust capillary electrophoresis method for the direct quantification of intact adenovirus particles in upstream and downstream processing samples | Talanta | 2017 | 33 |
| 37 | Unlocking the Potential of Saliva-Based Test to Detect HPV-16-Driven Oropharyngeal Cancer | Cancers | 2019 | 32 |
| 38 | Automated Design by Structure-Based Stabilization and Consensus Repair to Achieve Prefusion-Closed Envelope Trimers in a Wide Variety of HIV Strains | Cell Reports | 2020 | 32 |
| 39 | Immunity elicited by natural infection or Ad26.COV2.S vaccination protects hamsters against SARS-CoV-2 variants of concern | Science Translational Medicine | 2021 | 32 |
| 40 | Oral HPV16 DNA as a screening tool to detect early oropharyngeal squamous cell carcinoma | Cancer Science | 2020 | 31 |
| 41 | Adenovectors encoding RSV-F protein induce durable and mucosal immunity in macaques after two intramuscular administrations | Npj Vaccines | 2019 | 27 |
| 42 | Gene Transfer into Nonhuman Primate CD34+CD11b–Bone Marrow Progenitor Cells Capable of Repopulating Lymphoid and Myeloid Lineages | Human Gene Therapy | 1994 | 26 |
| 43 | Dynamics of the Humoral Immune Response to a Prime-Boost Ebola Vaccine: Quantification and Sources of Variation | Journal of Virology | 2019 | 26 |
| 44 | Adenovector 26 encoded prefusion conformation stabilized RSV-F protein induces long-lasting Th1-biased immunity in neonatal mice | Npj Vaccines | 2020 | 24 |
| 45 | Keratinocyte growth factor induced epithelial proliferation facilitates retroviral–mediated gene transfer to distal lung epithelia in vivo | Journal of Gene Medicine | 1999 | 23 |
| 46 | Stability and suitability for storage and distribution of Ad26.ZEBOV/MVA-BN®-Filo heterologous prime-boost Ebola vaccine | European Journal of Pharmaceutics and Biopharmaceutics | 2018 | 22 |
| 47 | Oral HPV16 Prevalence in Oral Potentially Malignant Disorders and Oral Cavity Cancers | Biomolecules | 2020 | 22 |
| 48 | Circumvention of chemotherapy-induced myelosuppression by transfer of themdr1 gene | Biotherapy (Dordrecht, Netherlands) | 1993 | 21 |
| 49 | SARS-CoV-2 binding and neutralizing antibody levels after Ad26.COV2.S vaccination predict durable protection in rhesus macaques | Nature Communications | 2021 | 21 |
| 50 | Impact of prophylactic vaccination strategies on Ebola virus transmission: A modeling analysis | PLoS ONE | 2020 | 20 |
